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Objective: Cystic medial degeneration (CMD) is a histologic abnormality that is common in aortic diseases such as aortic
dilation, aneurysm, or dissection. Although little is known about the mechanism underlying CMD, we have previously
demonstrated that angiotensin II signaling via angiotensin II type 2 receptor (AT2R) plays a central role in apoptosis of
vascular smooth muscle cells (VSMCs) occurring in CMD associated with Marfan syndrome. The aim of this study is to
elucidate the role of angiotensin II signaling in THE pathogenesis of aortic diseases associated with CMD.
Method: We investigated the effects of angiotensin-converting enzyme inhibitor (ACEI), temocapril (n 15), angiotensin
II receptor type-1 (AT1R) blocker, CS-866 (n  15), and vehicle control (n  17) on 0.25% -aminopropionitrile
monofumarate (BAPN)-induced aortic dissection and histopathologic findings in a rat model.
Results: Temocapril significantly prevented aortic dissection (P < .05), CMD (P < .01), and VSMC apoptosis (P < .01)
compared with vehicle control in BAPN-fed rats. However, CS-866 did not show any preventive effect. Reversed
transcriptase-polymerase chain reaction demonstrated that expression of both AT1R and AT2R was detected in control
rat aortas, and that AT2R expression was significantly upregulated in the aortas of BAPN-fed rats (P < .01). Blood
pressure was significantly and equally lowered in both temocapril and CS-866 groups compared with control.
Conclusions: Differential expression of angiotensin II receptors and AT2R signaling are involved in the pathogenesis of
CMD and aortic dissection in BAPN-fed rats. ACEIs might be of clinical value for the prevention and treatment of aortic
diseases related to CMD. (J Vasc Surg 2002;36:818-23.)
Cystic medial degeneration (CMD) is a histologic ab-
normality of the aorta that is characterized by fragmenta-
tion of elastic fibers, fibrosis with collagen production,
accumulation of amorphous matrix, and loss of cell nuclei.
This histologic change is commonly seen in patients who
have dilation, aneurysm, or dissection of the aorta associ-
ated with Marfan syndrome (MFS), but it is not specific to
MFS and sometimes also occurs in atherosclerosis related to
aging.1,2 Although little is known about the mechanism
underlying CMD, we reported previously that apoptosis of
vascular smooth muscle cells (VSMCs) is accelerated in
MFS aortas,3 and also demonstrated that angiotensin II
signaling via the angiotensin II type 2 receptor (AT2R)
plays an important role in VSMC apoptosis occurring in
CMD associated with MFS.3 On the basis of our previous
findings, we hypothesized that angiotensin-converting en-
zyme inhibitors (ACEIs), but not angiotensin II type-1
receptor (AT1R) blockers, could prevent CMD and aortic
dissection associated with VSMC apoptosis.
-Aminopropionitrile monofumarate (BAPN) is
known to induce aortic dissection in animals by inhibiting
the cross-linking of collagen fibers.4,5 BAPN-induced aor-
tic disease features vascular medial degeneration, fragmen-
tation of elastic fibers, and apoptosis of VSMCs, findings
that resemble the aortic changes in patients with CMD.6
In the present study, to investigate our hypothesis, we
examined the effects of an ACEI and an AT1R blocker on
VSMC apoptosis and CMD in rats with BAPN-induced
aortic dissection.
METHODS
Study protocol. Three-week-old Sprague-Dawley
rats were divided into the following three groups: a temo-
capril (ACEI, a kind gift from Sankyo Pharmaceutical Co,
Ltd.)-treated (5 mg/kg/day) group (n  15), a CS-866
(AT1R blocker, a kind gift from Sankyo Pharmaceutical
Co, Ltd.)-treated (3 mg/kg/day) group (n  14), and a
vehicle-treated control group (n  17). These drugs were
administered orally after 1 week of a diet containing 0.25%
BAPN. Systolic blood pressure was measured by the indi-
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rect tail cuff method at 2 weeks after the start of drug
administration. Animals that died during the study were
autopsied at that time, and animals that did not die were
sacrificed by an overdose of sodium pentobarbital at 5
weeks after the start of drug administration. The ascending
and descending aortas were harvested and immediately
placed into 4% paraformaldehyde (PFA) for fixation or into
normal saline for following experiments. The protocol of
this study was approved by the ethics committee for animal
experiments at our institution.
Histologic examination. The PFA-fixed aortas were
embedded in paraffin, cut into 4 m thick sections, and
stained with hematoxylin and eosin, Masson trichrome,
Alcian blue to detect mucopolysaccharides (MPS), and
Victoria blue to detect fragmentation of elastic fibers. Me-
dial degeneration was evaluated from the following histo-
logic features: (1) destruction and fragmentation of elastic
fibers demonstrated by Victoria blue staining and (2) dep-
osition of an amorphous substance stained by Alcian blue
representing MPS. The area of each of these features in
cross-sections obtained from the distal part of descending
aorta (undissected region) was measured and the Percent
area was calculated using Density Slice of NIH image 1.61
analysis software (Dako, Kyoto, Japan). Immunohisto-
chemical staining for smooth muscle -actin was carried
out with an anti-human smooth muscle -actin antibody
(1A4, Dako) using a LSAB kit (Dako). The investigators
performing histologic evaluation were blinded to the
grouping of the rats.
Evaluation of apoptosis. Terminal transferase-medi-
ated dUTP nick end-labeling (TUNEL) was carried out to
detect apoptotic VSMCs in deparaffinized 4-m sections
using an ApopTag in situ apoptosis detection kit (Oncor
Inc) according to the supplier’s instructions. Sections were
lightly counterstained with hematoxylin. Negative controls
included omission of terminal deoxynucleotidyl transferase
from the labeling mixture. Four sections were selected from
the distal part of descending aorta (undissected region) and
four fields per section were examined at a magnification of
400. Two independent investigators counted TUNEL-
positive VSMCs, and their observations were averaged.
Then the apoptotic index was calculated using the follow-
ing formula: 1000  (number of TUNEL-positive nuclei
per field/total number of nuclei per field).
Fig 1. BAPN-induced aortic dissection. A, Aorta with medial dissection at distal aortic arch from a BAPN-fed rat. B,
Photograph showing aorta with medial dissection (magnification, 10). Arrow indicates the initiation of aortic
dissection.
Table I. PCR primers used in this study
Gene Primer sequences PCR Products, bp
AT1R
Sense 5- GCCAAAGTCACCTGCATCAT -3 476
Antisense 5- AATTTTTTTCCCCAGAAAGCC -3
AT2R
Sense 5- TGAGTCCGCATTTAACTGC -3 494
Antisense 5- ACCACTGAGCATATTTCTCGGG -3
S16
Sense 5- AGGAGCGATTTGCTGGTGTGGA -3 103
Antisense 5- GCTACCAGGCCTTTGAGATGGA -3
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Reverse transcription-polymerase chain reaction
(RT-PCR). Total ribonucleic acid (RNA) was isolated
from aortic specimens using TRIzol reagent (Gibco BRL)
and reverse transcription of an aliquot (5 g) of the total
RNA sample was done using reverse transcriptase (Super-
script II, Gibco BRL). Then PCR of the complementary
DNA to detect the rat AT1R and AT2R genes was per-
formed by a programmed cycle of 94 for 30 seconds
(denaturation), 58 for 30 seconds (annealing) and 72 for
45 seconds (polymerization). As an internal control,
co-amplification of mouse S16 ribosomal protein was
performed. The sequences of the oligonucleotide prim-
ers used for PCR and the sizes of the predicted PCR
products are shown in Table I. The number of PCR
cycles was 35, and products were analyzed on agarose
gels. To determine whether the PCR was in the linear
range, various amounts of total RNA were used to amplify
each gene. Semiquantification of messenger ribonucleic
acid (mRNA) expression was achieved by densitometric
analysis using NIH image analysis software. This confirmed
the linear amplification of RNA at amounts from 0.1 to 5.0
g (data not shown), indicating that RT-PCR was per-
formed within the linear range in the present study.
Fig 2. Pathologic evaluation of cystic medial degeneration. A-F, Destruction and fragmentation were detected by use
of Victoria blue staining (upper panels; magnification, 100) and deposition of an amorphous protein was demon-
strated by Alcian blue staining (lower panels; magnification, 100). G, Percent area of elastic fibers is shown.
Temocapril significantly maintained elastic fiber tissue. *P  .01. H, Percent area of amorphous protein deposition is
shown. Temocapril significantly reduced Percent area of amorphous protein deposition. *P  .01.
Table II. Effects of ACEI and AT1R blocker on blood
pressure and aortic dissection
Systolic BP AD
Vehicle (n  17) 100 	 2.2 10/17 (59%)
Temocapril (n  15) 87.6 	 4.3* 4/15 (27%)*
CS-866 (n  14) 89.0 	 4.7* 7/14 (50%)
Data are mean 	 SD. BP, Blood pressure, AD, aortic dissection.
*P  .05 vs vehicle.
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Statistical analyses. Analysis was performed with SAS
System 8e software (SAS Institute Inc, Cary, NC). Results
are presented as the mean 	 standard deviation (SD). 
2
Test was applied for the analysis of dichotomous data.
Student t test was used for the analysis of continuous data.
The normality of the distribution of data was evaluated by
the Shapiro-Wilks one-sample test, and the F test was used
to assess the homogeneity of variance testing. One-way
analysis of variance (ANOVA) was used to test for statisti-
cally significant differences among the groups, and Dunnett
multiple comparison method was applied when appropri-
ate. Two-tailed probability (P) values of  .05 were con-
sidered to indicate statistical significance.
RESULTS
Effect of ACEI and AT1R blocker administration
on aortic dissection. Spontaneous dissection was ob-
served from the ascending aorta to the proximal portion of
the descending aorta in BAPN-fed rats (Fig 1). The aortas
were dilated and the findings resembled those in MFS
patients. Temocapril significantly prevented aortic dissec-
tion when compared with that in control rats (26.7% vs
64.7%, P  .05). In contrast, CS-866 had no statistically
significant effect on aortic dissection when compared with
that in control rats, although temocapril and CS-866 low-
ered blood pressure to the same degree (Table II).
Effect of ACEI and AT1R blocker administration
on CMD. Temocapril significantly maintained the area of
elastic fibers (P  .01) and significantly suppressed the
deposition of MPS when compared with vehicle-treated
controls (P  .01). In contrast, CS-866 had no effect (Fig
2), suggesting that the ACEI, but not the AT1R blocker,
could inhibit BAPN-induced CMD in rats.
Effect of ACEI and AT1R blocker administration
on VSMC apoptosis. Temocapril significantly inhibited
VSMC apoptosis, as evaluated by the TUNEL method,
when compared with that seen in vehicle-treated controls
(P .01). In contrast, CS-866 did not alter apoptosis (Fig
3).
Angiotensin II receptor expression. RT-PCR dem-
onstrated that both AT1R and AT2R were expressed in
control rat aortas, and that AT2R mRNA expression was
significantly upregulated in the aortas of BAPN-fed rats
(P  .01, Fig 4).
DISCUSSION
Several studies have demonstrated that angiotensin II
plays a pivotal role in the pathogenesis of aortic dis-
ease.3,7-10 Daugherty et al7 reported that aortic aneurysm
with medial dissection could be induced by angiotensin II
infusion in apo E–deficient mice, and Nishijo et al8 showed
that salt-sensitive aortic dissection occurred in mice with
overproduction of angiotensin II. We have previously
shown by organ culture that AT2R expression is upregu-
lated, and that ACEIs (but not AT1R blockers) can sup-
presses VSMC apoptosis in aortas from patients with MFS.3
In addition, we have hypothesized that this inhibition of
VSMC apoptosis by ACEI might be useful for the preven-
tion and treatment of CMD or aortic dissection in patients
Fig 3. Vascular smooth muscle cell apoptosis evaluated by TUNEL staining (magnification, 100). Arrows show
Brown spots, which indicate TUNEL-positive cells. A-C, The effects of ACEI and AT1R blocker on apoptosis are
shown. D, Rat without BAPN feeding for negative control. E, Rat thymus tissue for positive control of TUNEL
staining. F, Temocapril significantly reduced apoptotic VSMCs. However, apoptotic VSMCs were not altered by
CS-866. *P  .01.
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with MFS.3 To test our hypothesis, we planned this in vivo
study.
We demonstrated two major findings by using rats with
BAPN-induced aortic dissection in the present study. First,
an ACEI (but not AT1R blocker) could prevent CMD,
VSMC apoptosis, and aortic dissection in BAPN-fed rats.
This result is compatible with the hypothesis that was based
on our previous in vitro studies.3 Liao et al10 reported that
the creation of experimental abdominal aortic aneurysms
by elastase infusion was also inhibited by ACEIs (not by
AT1R blockers) in rats. They also demonstrated the lack of
association between blood pressure and occurrence of aor-
tic aneurysm, but they did not reach the basic mechanism
underlying the difference of inhibitory effect between
ACEIs and AT1R blockers.10
Second, we showed that angiotensin II receptor expres-
sion was altered in diseased rat aortas, leading to a possible
mechanism for the difference in the preventive effect on
BAPN-induced aortic diseases between ACEI and AT1R
blocker. Most of the known effects of angiotensin II in
adults are attributable to AT1R, and signaling via AT2R has
been shown to antagonize AT1R signaling.11 Recent stud-
ies have suggested that AT2R may play an important role in
the regulation of apoptosis.12,13 AT2R expression level is
generally high in fetal tissues but decreases rapidly after
birth,14 although enhanced expression has been reported in
adults with cardiovascular diseases such as cardiac hypertro-
phy,15 atherosclerosis,16 hypertension,17 myocardial in-
farction,18 and aortic disease associated with MFS.3 We
demonstrated that both the AT1R and the AT2R were
expressed in the rat aorta and that AT2R expression was
upregulated in rats with BAPN-induced aortic dissection.
Taking our previous in vitro finding that AT2R medi-
ates VSMC apoptosis in MFS aortas3 together with the
finding of the present in vivo study that an ACEI (but not
an AT1R blocker) can prevent aortic dissection in BAPN-
fed rats, it appears that signaling via the AT2R to promote
apoptosis may play a central role in pathogenesis of CMD
and aortic dissection in this rat model.
Inhibition of the renin-angiotensin system (RAS) is
believed to be important for the prevention of cardiovascu-
lar remodeling. In fact, many recent studies have proved
that RAS-inhibition therapy can improve the prognosis and
the quality of life in patients with heart failure.19 In the
context of RAS inhibition, ACEIs and AT1R blockers
might have the same effect when AT1R expression is abun-
dant. However, in diseases associated with increased AT2R
expression, the action of ACEIs and AT1R blockers should
be different, as was shown in the present study.
On the other hand, ACEIs not only block the RAS
pathway but also inhibit the breakdown of bradykinin and
then activate nitric oxide synthase. Thus, is possible that the
beneficial effects of ACEIs in the present study may result
from effects other than RAS inhibition. Further experi-
Fig 4. A, RT-PCR for AT1R, AT2R, and S16 as an internal control. B, Ratio of AT2R mRNA expression/S16 mRNA
expression was significantly higher in BAPN-fed rat aortas than in aortas from rats without BAPN, whereas ratio of
AT1R mRNA/S16 mRNA expression was not changed. *P  .01.
JOURNAL OF VASCULAR SURGERY
October 2002822 Nagashima et al
ments are necessary to elucidate the contribution of these
alternative effects of ACEIs in the vasculature.
CONCLUSION
Our results suggest that differential expression of an-
giotensin II receptors and AT2R signaling are involved in
the pathogenesis of CMD and aortic dissection in BAPN-
fed rats. ACEIs might be of clinical value for the prevention
and treatment of aortic diseases related to CMD.
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